Remarkably, giant GC as well as increased TFH and TPH cells resolved in the AID-ΔE4a patients after initiation of IRT, suggesting that provision of correctly mutated antibodies besides preventing severe infections may also dampen immune dysregulation in these patients. The gene discussed is TPH1; the disease is infection.